PMID- 25155878 OWN - NLM STAT- MEDLINE DCOM- 20160119 LR - 20211021 IS - 1476-5578 (Electronic) IS - 1359-4184 (Linking) VI - 20 IP - 5 DP - 2015 May TI - Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time. PG - 602-8 LID - 10.1038/mp.2014.83 [doi] AB - One of the leading neurobiological hypotheses on depression states that decreased expression of brain-derived neurotrophic factor (BDNF) contributes to depression. This is supported by consistent findings of low serum BDNF levels in depressed patients compared with non-depressed controls. Whereas it has been generally assumed that this is a state characteristic of depression, strong inferences about state or trait effects require a longitudinal study design. To investigate the longitudinal association between serum BDNF and depression, we measured serum BDNF, (current and past) depression status, use of antidepressants, and all potential covariates at baseline and after 2 years in 1751 individuals, consisting of patients with an incident (n=153), remitted (n=420) and persistent depression (n=310) and non-depressed controls (n=868). We analyzed change/differences in serum BDNF across these four groups with analyses of covariance adjusted for covariates and baseline BDNF value, together with the effects of starting and stopping antidepressant treatment. Our analyses revealed a significant difference for the depression course groups (P=0.007). Compared with non-depressed controls, persistently depressed and remitted patients had a steeper decrease of BDNF levels over time (-1.33 (P=0.001) and -0.97 ng ml(-1) (P=0.011), respectively), whereas BDNF reductions in patients with incident depression were similar to those in healthy controls. Initiation or discontinuation of antidepressants was not associated with BDNF change (P=0.72). These findings suggest that BDNF not only contributes to depression, but that depression in turn may also contribute to low BDNF. FAU - Bus, B A A AU - Bus BA AD - Department of Psychiatry, Nijmegen Centre for Evidence Based Practice (NCEBP) Radboud University Medical Centre, Nijmegen, The Netherlands. FAU - Molendijk, M L AU - Molendijk ML AD - Clinical, Health and Neuropsychology Unit, Leiden University, Leiden, the Netherlands and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands. FAU - Tendolkar, I AU - Tendolkar I AD - 1] Department of Psychiatry, Nijmegen Centre for Evidence Based Practice (NCEBP) Radboud University Medical Centre, Nijmegen, The Netherlands [2] Faculty of Medicine and LVR Clinic for Psychiatry and Psychotherapy, University of Duisburg-Essen, Germany [3] Donders Institute for Brain Cognition and Behaviour, Centre for Neuroscience, Nijmegen, The Netherlands. FAU - Penninx, B W J H AU - Penninx BW AD - 1] Department of Psychiatry and EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands [3] Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands. FAU - Prickaerts, J AU - Prickaerts J AD - Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. FAU - Elzinga, B M AU - Elzinga BM AD - Clinical, Health and Neuropsychology Unit, Leiden University, Leiden, the Netherlands and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands. FAU - Voshaar, R C O AU - Voshaar RC AD - 1] Department of Psychiatry, Nijmegen Centre for Evidence Based Practice (NCEBP) Radboud University Medical Centre, Nijmegen, The Netherlands [2] Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140826 PL - England TA - Mol Psychiatry JT - Molecular psychiatry JID - 9607835 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Adult MH - Antidepressive Agents/therapeutic use MH - Brain-Derived Neurotrophic Factor/*blood MH - Child MH - Child Abuse/psychology MH - Chronic Disease MH - Depression/*blood/classification/drug therapy MH - Female MH - Humans MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Psychiatric Status Rating Scales MH - Retrospective Studies MH - Statistics, Nonparametric EDAT- 2014/08/27 06:00 MHDA- 2016/01/20 06:00 CRDT- 2014/08/27 06:00 PHST- 2014/01/06 00:00 [received] PHST- 2014/05/02 00:00 [revised] PHST- 2014/06/17 00:00 [accepted] PHST- 2014/08/27 06:00 [entrez] PHST- 2014/08/27 06:00 [pubmed] PHST- 2016/01/20 06:00 [medline] AID - mp201483 [pii] AID - 10.1038/mp.2014.83 [doi] PST - ppublish SO - Mol Psychiatry. 2015 May;20(5):602-8. doi: 10.1038/mp.2014.83. Epub 2014 Aug 26.